Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ISAVUCONAZONIUM SULFATE, with a corresponding US DMF Number 38251.
Remarkably, this DMF maintains an Active status since its submission on March 31, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 28, 2024, and payment made on June 13, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II